1
|
Block ML, Zecca L and Hong JS:
Microglia-mediated neurotoxicity: uncovering the molecular
mechanisms. Nature Rev Neurosci. 8:57–69. 2007. View Article : Google Scholar : PubMed/NCBI
|
2
|
Hanisch UK and Kettenmann H: Microglia:
active sensor and versatile effector cells in the normal and
pathologic brain. Nat Neurosci. 10:1387–1394. 2007. View Article : Google Scholar : PubMed/NCBI
|
3
|
Gehrmann J, Matsumoto Y and Kreutzberg GW:
Microglia: intrinsic immuneffector cell of the brain. Brain Res
Brain Res Rev. 20:269–287. 1995. View Article : Google Scholar : PubMed/NCBI
|
4
|
Innamorato NG, Lastres-Becker I and
Cuadrado A: Role of microglial redox balance in modulation of
neuroinflammation. Curr Opin Neurol. 22:308–314. 2009. View Article : Google Scholar : PubMed/NCBI
|
5
|
Lynch MA: The multifaceted profile of
activated microglia. Mol Neurobiol. 40:139–156. 2009. View Article : Google Scholar : PubMed/NCBI
|
6
|
Li YH, Teng P, Wang Y, Zhang YM, Ma CJ and
Pu J: Expression and regulation of HSP60 in activated microglia
cells. J Ningxia Med Univ. 8:712–714. 2011.
|
7
|
Zhang D, Sun L, Zhu H, Wang L, Wu W, Xie J
and Gu J: Microglial LOX-1 reacts with extracellular HSP60 to
bridge neuroinflammation and neurotoxicity. Neurochem Int.
61:1021–1035. 2012. View Article : Google Scholar : PubMed/NCBI
|
8
|
Lehnardt S, Schott E, Trimbuch T, Laubisch
D, Krueger C, Wulczyn G, Nitsch R and Weber JR: A vicious cycle
involving release of heat shock protein 60 from injured cells and
activation of toll-like receptor 4 mediates neurodegeneration in
the CNS. J Neurosci. 28:2320–2331. 2008. View Article : Google Scholar : PubMed/NCBI
|
9
|
Xia W, Han J, Huang G and Ying W:
Inflammation in ischaemic brain injury: current advances and future
perspectives. Clin Exp Pharmacol Physiol. 37:253–258. 2010.
View Article : Google Scholar : PubMed/NCBI
|
10
|
Perry VH, Nicoll JA and Holmes C:
Microglia in neurodegenerative disease. Nat Rev Neurol. 6:193–201.
2010. View Article : Google Scholar
|
11
|
Stirling DP, Khodarahmi K, Liu J, McPhail
LT, McBride CB, Steeves JD, Ramer MS and Tetzlaff W: Minocycline
treatment reduces delayed oligodendrocyte death, attenuates axonal
dieback, and improves functional outcome after spinal cord injury.
J Neurosci. 24:2182–2190. 2004. View Article : Google Scholar
|
12
|
Choi SH, Lee DY, Chung ES, Hong YB, Kim SU
and Jin BK: Inhibition of thrombin-induced microglial activation
and NADPH oxidase by minocycline protects dopaminergic neurons in
the substantia nigra in vivo. J Neurochem. 95:1755–1765. 2005.
View Article : Google Scholar : PubMed/NCBI
|
13
|
Li SY, Yang D, Yeung CM, Yu WY, Chang RC,
So KF, Wong D and Lo AC: Lycium barbarum polysaccharides
reduce neuronal damage, blood-retinal barrier disruption and
oxidative stress in retinal ischemia/reperfusion injury. PLoS One.
6:e163802011. View Article : Google Scholar
|
14
|
Li XM, Ma YL and Liu XJ: Effect of the
Lycium barbarum polysaccharides on age-related oxidative
stress in aged mice. J Ethnopharmacol. 111:504–511. 2007.
|
15
|
Tang WM, Chan E, Kwok CY, Lee YK, Wu JH,
Wan CW, Chan RY, Yu PH and Chan SW: A review of the anticancer and
immunomodulatory effects of Lycium barbarum fruit.
Inflammopharmacology. 20:307–314. 2012. View Article : Google Scholar : PubMed/NCBI
|
16
|
Gong H, Shen P, Jin L, Xing C and Tang F:
Therapeutic effects of Lycium barbarum polysaccharide (LBP)
on irradiation or chemotherapy-induced myelosuppressive mice.
Cancer Biother Radiopharm. 20:155–162. 2005.
|
17
|
Ho YS, Yu MS, Lai CS, et al:
Characterizing the neuroprotective effects of alkaline extract of
Lycium barbarum on beta-amyloid peptide neurotoxicity. Brain
Res. 1158:123–134. 2007. View Article : Google Scholar : PubMed/NCBI
|
18
|
Ho YS, Yu MS, Yik SY, So KF, Yuen WH and
Chang RC: Polysaccharides from wolfberry antagonizes glutamate
excitotoxicity in rat cortical neurons. Cell Mol Neurobiol.
29:1233–1244. 2009. View Article : Google Scholar : PubMed/NCBI
|
19
|
Zhu J, Shao CY, Yang W, Zhang XM, Wu ZY,
Zhou L, Wang XX, Li YH, Xia J, Luo JH and Shen Y: Chronic zinc
exposure decreases the surface expression of NR2A-containing NMDA
receptors in cultured hippocampal neurons. PloS One. 7:e460122012.
View Article : Google Scholar : PubMed/NCBI
|
20
|
Sarkar FH, Li Y, Wang Z and Kong D:
NF-kappaB signaling pathway and its therapeutic implications in
human diseases. Int Rev Immunol. 27:293–319. 2008. View Article : Google Scholar : PubMed/NCBI
|
21
|
Hayoun D, Kapp T, Edri-Brami M, Ventura T,
Cohen M, Avidan A and Lichtenstein RG: HSP60 is transported through
the secretory pathway of 3-MCA-induced fibrosarcoma tumour cells
and undergoes N-glycosylation. FEBS J. 279:2083–2095. 2012.
View Article : Google Scholar : PubMed/NCBI
|
22
|
Rizzo M, Macario AJ, de Macario EC,
Gouni-Berthold I, Berthold HK, Rini GB, Zummo G and Cappello F:
Heat shock protein-60 and risk for cardiovascular disease. Curr
Pharm Des. 17:3662–3668. 2011. View Article : Google Scholar : PubMed/NCBI
|
23
|
Kreutzberg GW: Microglia: a sensor for
pathological events in the CNS. Trends Neurosci. 19:312–318. 1996.
View Article : Google Scholar : PubMed/NCBI
|
24
|
Lai AY and Todd KG: Microglia in cerebral
ischemia: molecular actions and interactions. Can J Physiol
Pharmacol. 84:49–59. 2006.PubMed/NCBI
|
25
|
Chen J, Zhou Y, Mueller-Steiner S, Chen
LF, Kwon H, Yi S, Mucke L and Gan L: SIRT1 protects against
microglia-dependent amyloid-beta toxicity through inhibiting
NF-kappaB signaling. J Biol Chem. 280:40364–40374. 2005. View Article : Google Scholar : PubMed/NCBI
|
26
|
Karlstetter M, Lippe E, Walczak Y, Moehle
C, Aslanidis A, Mirza M and Langmann T: Curcumin is a potent
modulator of microglial gene expression and migration. J
Neuroinflammation. 8:1252011. View Article : Google Scholar : PubMed/NCBI
|
27
|
Park HY, Han MH, Park C, Jin CY, Kim GY,
Choi IW, Kim ND, Nam TJ, Kwon TK and Choi YH: Anti-inflammatory
effects of fucoidan through inhibition of NF-κB, MAPK and Akt
activation in lipopolysaccharide-induced BV2 microglia cells. Food
Chem Toxicol. 49:1745–1752. 2011.
|
28
|
Soria JA, Arroyo DS, Gaviglio EA,
Rodriguez-Galan MC, Wang JM and Iribarren P: Interleukin 4 induces
the apoptosis of mouse microglial cells by a caspase-dependent
mechanism. Neurobiol Dis. 43:616–624. 2011. View Article : Google Scholar : PubMed/NCBI
|
29
|
Burguillos MA, Deierborg T, Kavanagh E,
Persson A, Hajji N, Garcia-Quintanilla A, Cano J, Brundin P,
Englund E, Venero JL and Joseph B: Caspase signalling controls
microglia activation and neurotoxicity. Nature. 472:319–324. 2011.
View Article : Google Scholar : PubMed/NCBI
|
30
|
Gu JH, Ge JB, Li M, Wu F, Zhang W and Qin
ZH: Inhibition of NF-κB activation is associated with
anti-inflammatory and anti-apoptotic effects of Ginkgolide B in a
mouse model of cerebral ischemia/reperfusion injury. Eur J Pharm
Sci. 47:652–660. 2012.
|
31
|
Woods DC, White YA, Dau C and Johnson AL:
TLR4 activates NF-κB in human ovarian granulosa tumor cells.
Biochem Biophys Res Commun. 409:675–680. 2011.
|
32
|
Kapitein B, Aalberse JA, Klein MR, de
Jager W, Hoekstra MO, Knol EF and Prakken BJ: Recognition of
self-heat shock protein 60 by T cells from patients with atopic
dermatitis. Cell Stress Chaperones. 18:87–95. 2013. View Article : Google Scholar : PubMed/NCBI
|
33
|
Lin L, Kim SC, Wang Y, Gupta S, Davis B,
Simon SI, et al: HSP60 in heart failure: abnormal distribution and
role in cardiac myocyte apoptosis. Am J Physiol Heart Circ Physiol.
293:H2238–H2247. 2007. View Article : Google Scholar : PubMed/NCBI
|
34
|
Wang Y, Chen L, Hagiwara N and Knowlton
AA: Regulation of heat shock protein 60 and 72 expression in the
failing heart. J Mol Cell Cardiol. 48:360–366. 2010. View Article : Google Scholar : PubMed/NCBI
|